TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
BMEA

Biomea Fusion Inc

Healthcare · Biotechnology

1.80$ +2.9% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Cash Flow

Biomea Fusion Inc (BMEA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -70 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow BMEA
Line item 2019 2020 2021 2022 2023 2024 2025
-1.3 -4.5 -35 -62 -97 -120 -70
0.0 0.1 0.2 0.7 1.5 1.7 1.4
0.0 0.3 6.2 10 14 19 9.5
0.4 0.4 7.5 10
-0.1 0.4 -1.6 7.7 2.3 -5.1 -3.7
0.1 0.1 3.2 1.0 3.4 0.4 0.0
-0.1 -0.1 -33 27 -2.2 -0.4
153 1.2
0.0 0.0 0.0 0.0 0.0
1.4 66 153 1.2 164 1.7 68
0.2 61 84 -34 65 -119 -2.5
-1.3 -4.5 -39 -63 -100 -120 -70

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?